PEVAX
Price
$16.97
Change
+$0.20 (+1.19%)
Updated
Jan 30 closing price
Net Assets
N/A
VSIAX
Price
$89.06
Change
+$0.96 (+1.09%)
Updated
Jan 30 closing price
Net Assets
58.32B
Ad is loading...

PEVAX vs VSIAX

Header iconPEVAX vs VSIAX Comparison
Open Charts PEVAX vs VSIAXBanner chart's image
PACE Small/Medium Co Value Equity A
Price$16.97
Change+$0.20 (+1.19%)
VolumeN/A
Net AssetsN/A
Vanguard Small Cap Value Index Admiral
Price$89.06
Change+$0.96 (+1.09%)
VolumeN/A
Net Assets58.32B
PEVAX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEVAX vs. VSIAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEVAX is a StrongBuy and VSIAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSIAX pays higher dividends than PEVAX: VSIAX (2.01) vs PEVAX (0.46). PEVAX was incepted earlier than VSIAX: PEVAX (24 years) vs VSIAX (13 years). PEVAX is a more actively managed with annual turnover of: 36.00 vs. VSIAX (16.00). PEVAX has a lower initial minimum investment than VSIAX: PEVAX (1000) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 17.45 vs. PEVAX (-4.73). VSIAX return over 5 years is better than : 57.90 vs. PEVAX (-8.90).
PEVAXVSIAXPEVAX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years13 years-
Gain YTD2.8833.44084%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A58.3B-
Annual Yield % from dividends0.462.0123%
Returns for 1 year-4.7317.45-27%
Returns for 3 years-22.9221.69-106%
Returns for 5 years-8.9057.90-15%
Returns for 10 years-9.65107.64-9%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XP14.000.69
+5.18%
XP
NEGG0.440.02
+4.41%
Newegg Commerce
MCY50.801.26
+2.54%
Mercury General Corp
ASIX31.19-0.68
-2.13%
AdvanSix
ENSC6.71-0.22
-3.17%
Ensysce Biosciences